Literature DB >> 25217372

Can Bayliss and Starling gut hormones cure a worldwide pandemic?

R V Scott1, T M Tan2, S R Bloom2.   

Abstract

Bayliss and Starling first coined the term 'hormone' with reference to secretin, a substance they found that was produced by the gut, but released into the blood stream to act at a distance. The intestine is now known as the largest endocrine organ in the body, and it produces numerous hormones with a wide range of functions. These include controlling appetite and energy homeostasis. Obesity is one of the greatest health threats facing the world today. At present, the only successful treatment is surgery. Bariatric procedures such as the Roux-en-Y bypass work by elevating gut hormones that induce satiety. Significant research has gone into producing versions of these hormones that can be delivered therapeutically to treat obesity. This review looks at the role of gut hormones in obesity, and the development of gut hormone-derived obesity treatments.
© 2014 The Authors. The Journal of Physiology © 2014 The Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25217372      PMCID: PMC4262331          DOI: 10.1113/jphysiol.2014.272955

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  150 in total

Review 1.  Trends in mortality in bariatric surgery: a systematic review and meta-analysis.

Authors:  Henry Buchwald; Rhonda Estok; Kyle Fahrbach; Deirdre Banel; Isabella Sledge
Journal:  Surgery       Date:  2007-10       Impact factor: 3.982

2.  Gastrointestinal hormones and the dialogue between gut and brain.

Authors:  Graham J Dockray
Journal:  J Physiol       Date:  2014-02-24       Impact factor: 5.182

3.  Bioactive enteroglucagon (oxyntomodulin): present knowledge on its chemical structure and its biological activities.

Authors:  D Bataille; C Gespach; K Tatemoto; J C Marie; A M Coudray; G Rosselin; V Mutt
Journal:  Peptides       Date:  1981       Impact factor: 3.750

4.  Ghrelin enhances appetite and increases food intake in humans.

Authors:  A M Wren; L J Seal; M A Cohen; A E Brynes; G S Frost; K G Murphy; W S Dhillo; M A Ghatei; S R Bloom
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

5.  c-Jun/AP-1 is required for CCK-induced pancreatic acinar cell dedifferentiation and DNA synthesis in vitro.

Authors:  Lili Guo; Maria Dolors Sans; Yanan Hou; Stephen A Ernst; John A Williams
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-29       Impact factor: 4.052

6.  Ghrelin increases food intake in obese as well as lean subjects.

Authors:  M R Druce; A M Wren; A J Park; J E Milton; M Patterson; G Frost; M A Ghatei; C Small; S R Bloom
Journal:  Int J Obes (Lond)       Date:  2005-09       Impact factor: 5.095

7.  C-terminal octapeptide of cholecystokinin decreases food intake in obese men.

Authors:  X Pi-Sunyer; H R Kissileff; J Thornton; G P Smith
Journal:  Physiol Behav       Date:  1982-10

Review 8.  Surgery for obesity.

Authors:  Jill L Colquitt; Joanna Picot; Emma Loveman; Andrew J Clegg
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

9.  The post-prandial pattern of gut hormones is related to magnitude of weight-loss following gastric bypass surgery: a case-control study.

Authors:  Tom Gerner; Odd-Erik Johansen; Mona Olufsen; Peter A Torjesen; Arnljot Tveit
Journal:  Scand J Clin Lab Invest       Date:  2014-01-28       Impact factor: 1.713

10.  Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects.

Authors:  Juris J Meier; Michael A Nauck; Daniel Kranz; Jens J Holst; Carolyn F Deacon; Dirk Gaeckler; Wolfgang E Schmidt; Baptist Gallwitz
Journal:  Diabetes       Date:  2004-03       Impact factor: 9.461

View more
  3 in total

1.  Identification of 5-hydroxytryptamine-producing cells by detection of fluorescence in paraffin-embedded tissue sections.

Authors:  Y Kaneko; N Onda; Y Watanabe; M Shibutani
Journal:  Eur J Histochem       Date:  2016-09-29       Impact factor: 3.188

2.  Metabolic improvements following Roux-en-Y surgery assessed by solid meal test in subjects with short duration type 2 diabetes.

Authors:  Sudha S Shankar; Lori A Mixson; Manu Chakravarthy; Robin Chisholm; Anthony J Acton; RoseMarie Jones; Samer G Mattar; Deborah L Miller; Lea Petry; Chan R Beals; S Aubrey Stoch; David E Kelley; Robert V Considine
Journal:  BMC Obes       Date:  2017-03-01

3.  Serotonin-secreting enteroendocrine cells respond via diverse mechanisms to acute and chronic changes in glucose availability.

Authors:  Leah Zelkas; Ravi Raghupathi; Amanda L Lumsden; Alyce M Martin; Emily Sun; Nick J Spencer; Richard L Young; Damien J Keating
Journal:  Nutr Metab (Lond)       Date:  2015-12-15       Impact factor: 4.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.